SRRK Q2 2019 Earnings — Scholar Rock Holding Corporation Revenue & Financial Results | Market Cap Arena

SRRKScholar Rock Holding Corporation

$4B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

-$9M-172.2% margin

Operating Income

-$13M-265.6% margin

Net Income

-$13M-248.6% margin

EPS (Diluted)

$-0.48

QoQ Revenue Growth

+62.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$197M

Total Liabilities

$68M

Stockholders' Equity

$129M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	-$9M	-$11M	+24.1%
Operating Income	-$13M	-$15M	+10.1%
Net Income	-$13M	-$15M	+14.8%